NASDAQ: FFRFf Eai Robotics Ecosystem Inc Stock
$1.23+0.01 (+0.82%)
Updated Oct 2, 2026
FFR Price
$1.23
Fair Value Price
N/A
Market Cap
$24.89M
52 Week Low
$0.59
52 Week High
$5.97
P/E
-0.13x
P/B
4.38x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$22.90M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.3
Operating Cash Flow
-$12M
Beta
0.83
Next Earnings
Nov 13, 2026
Ex-Dividend
N/A
Next Dividend
N/A
FFR Overview
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FFR's potential to beat the market
- FFR doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Software Infrastructure
Industry Rating
C
FFR
RankedUnranked of 131
RankedUnranked of 131
Be the first to know about important FFR news, forecast changes, insider trades & much more!
FFR News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FFR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FFR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FFR is good value based on its book value relative to its share price (4.38x), compared to the US Software - Infrastructure industry average (8.59x)
P/B vs Industry Valuation
FFR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more FFR due diligence checks available for Premium users.
Valuation
FFR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.13x
Industry
260.36x
Market
49.66x
FFR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.38x
Industry
8.59x
FFR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FFR's financial health
Profit margin
Revenue
$0.0
Net Income
-$4.2M
Profit Margin
0%
FFR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$7.4M
Liabilities
$1.7M
Debt to equity
0.3
FFR's short-term assets ($6.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FFR's short-term assets ($6.34M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FFR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FFR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.4M
Investing
$9.8M
Financing
-$12.0M
FFR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FFR vs Software Infrastructure Stocks
Ff Eai Robotics Ecosystem Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.